<html>
<head>PUBMED IDs for HCA587</head>
<body bgcolor='#C5F0F2'><h1>HCA587</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12097419/'>Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.</a> July 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12679909/'>Expression, purification and serological analysis of hepatocellular carcinoma associated antigen HCA587 in insect cells.</a> April 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12920247/'>HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma.</a> August 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15807856/'>Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.</a> April 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/24866244/'>Cancer-testis antigen HCA587/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin-proteasome pathway.</a> August 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27076846/'>MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2.</a> April 15  2016<br></body></html>
